期刊文献+

过表达von Hippel-Lindau蛋白抑制小鼠结肠癌的生长及肝转移的研究

Overexpression of von Hippel-Lindau protein inhibits the growth of colon cancer and liver metastasis in mice
下载PDF
导出
摘要 目的本研究拟探索在体内和体外过表达VHL蛋白能否抑制结肠癌的生长和转移。方法 应用含有VHL的腺病毒在体外及体内过表达VHL蛋白。在体外检测结肠癌细胞CT26的增殖、凋亡和迁移,应用Western blot检测相关蛋白的表达。建立结肠癌皮下移植瘤和肝转移癌模型并判断治疗效果。结果过表达VHL蛋白通过调控COX-2、Bcl-2和MMP-9的表达抑制结肠癌细胞CT26增殖和侵袭,促进CT26细胞凋亡。在体内过表达VHL蛋白可抑制结肠癌皮下移植瘤的增长和结肠癌的肝转移。结论 过表达VHL蛋白可抑制结肠癌的增长和转移,促进结肠癌细胞凋亡,提示VHL可能作为结肠癌治疗的一个潜在靶点。 Objective To investigate whether overexpression of VHL can inhibit the growth and metasta-sis of colon cancer .Methods Adenovirus vectors containing VHL were used to overexpress VHL protein in vitro and in vivo.The proliferation,apoptosis and migration of colon cancer cells CT 26 were examined in vitro.The ex-pressions of related proteins were detected by Western blot analysis .Subcutaneous and liver metastasis of colon cancer models were established and the therapeutic effects were evaluated .Results Overexpression of VHL pro-tein inhibited the proliferation and invasion of CT26,and promoted the apoptosis of CT26 via the regulation of COX-2,Bcl-2 and MMP-9.Overexpression of VHL protein inhibited the growth of subcutaneous colon cancer and liver metastasis in vivo .Conclusion Overexpression of VHL protien can inhibit the growth and metastasis of colon cancer ,and enhance the apoptosis of colon cancer ,indicating that VHL can be used as a potential target for colon cancer therapy .
出处 《实用肿瘤学杂志》 CAS 2016年第5期385-390,共6页 Practical Oncology Journal
基金 国家自然科学基金(81200304) 中国博士后科学基金(2012M520770) 黑龙江省自然科学基金(QC2012C112) 黑龙江省博士后科学基金(LBH-Z12162) 哈尔滨医科大学附属第一医院科研基金(2012BS005)
关键词 von Hippel-Lindau蛋白 结肠癌 肝转移 von Hippel-Lindau protein Colon cancer Liver metastasis
  • 相关文献

参考文献15

  • 1Lonser RR, Glenn GM, Wahher M, et al. von Hippel - Lin- dau disease [J] Lancet ,2003,36 l (9374) :2059 - 2067.
  • 2Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia- inducible factors for oxygen - dependent proteolysis [ J ]. Nature, 1999,399 (6733) :271 -275.
  • 3Yang H, Minamishima YA,Yan Q,et al. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF - kappaB agonist Card9 by CK2 [ J 1- Mol Cell, 2007,28 (1):15-27.
  • 4Kurban G, Duplan E, Ramlal N, et al. Collagen matrix as- sembly is driven by the interaction of von Hippel - Lindau tumor suppressor protein with hydroxylated collagen IV al- pha 2 [ J ]. Oncogene ,2008,27 ( 7 ) : 1004 - 1012.
  • 5Wang J, Ma Y, Jiang H, et al. Overexpression of yon Hippel -Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice [ J ]. J Hepatol, 2011,55 (2) :359 -368.
  • 6Giles RH, Lolkema MP, Snijekers CM, et al. Interplay be- tween VHL/HIFlalpha and Wnt/beta -catenin pathways during colorectal tumorigenesis [ J 1- Oncogene, 2006, 25 ( 21 ) : 3065 - 3070.
  • 7Karanikas M, Esebidis A. Increasing incidence of colon cancer in patients < 50 years old: a new entity [ J 1. Ann Transl Med,2016,4(9) :164 - 172.
  • 8Kelly ME, Spolverato G, L~ GN, et al. Synchronous coloree- tal liver metastasis : a network meta - analysis review compa- ring classical, combined, and liver - first surgical strategies [J]. J Surg Oncol,2015,111 (3) :341 -351.
  • 9Sonoshita M,Takaku K, Sasaki N, et al. Acceleration of in- testinal polyposis through prostaglandin receptor EP2 in Apc ( Delta 716 ) knockout mice [ J ]. Nat Med,2001,7 (9) : 1048 - 1051.
  • 10Arber N, Eagle C J, Spicak J, et al. Celecoxib for the pre- vention of coloreetal adenomatous polyps [ J ]. N Engl J Med ,2006,355 (9) :885 - 895.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部